Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Onchocerciasis--river blindness.

Claes D Enk1

  • 1Department of Dermatology, The Hadassah-Hebrew University Medical Center, Jerusalem, Israel. enk@md.huji.ac.il

Clinics in Dermatology
|May 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis.

EMBO molecular medicine·2022
Same author

Isolated solar angioedema: A systematic review of the literature.

Photodermatology, photoimmunology & photomedicine·2021
Same author

Self-administered daylight-activated photodynamic therapy for the treatment of hand eczema: A prospective proof-of-concept study.

Dermatologic therapy·2020
Same author

Intralesional sodium stibogluconate under inhaled anesthesia for the treatment of cutaneous leishmaniasis in children: A retrospective cohort.

Journal of the American Academy of Dermatology·2019
Same author

Daylight photodynamic therapy for the treatment of actinic cheilitis.

Photodermatology, photoimmunology & photomedicine·2018
Same author

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

Immunity·2018

Onchocerciasis, a parasitic worm infection, causes severe itching and blindness. Doxycycline, targeting Wolbachia, shows promise in reducing parasite load and preventing eye disease, offering a new treatment avenue.

Area of Science:

  • Parasitology
  • Tropical Medicine
  • Infectious Diseases

Background:

  • Onchocerciasis, caused by Onchocerca volvulus, is a significant health issue in Africa, Arabia, and the Americas.
  • Spread by black fly bites, it causes debilitating skin conditions and potentially blinding eye disease.
  • Current control relies on mass prevention programs and ivermectin, but resistance and limitations exist.

Purpose of the Study:

  • To explore novel chemotherapeutic strategies for onchocerciasis treatment and control.
  • To investigate the efficacy of targeting Wolbachia endosymbionts in Onchocerca volvulus.

Main Methods:

  • Review of recent research on chemotherapeutic approaches for onchocerciasis.
  • Focus on doxycycline's potential role in targeting filarial Wolbachia symbionts.

Related Experiment Videos

Main Results:

  • Doxycycline, at 100 mg/d for 6 weeks, may effectively reduce filarial load.
  • This treatment approach shows potential in preventing ocular manifestations of onchocerciasis.

Conclusions:

  • Targeting Wolbachia symbionts with doxycycline represents a promising new strategy for onchocerciasis management.
  • Further research is warranted to establish doxycycline's role in onchocerciasis treatment protocols.